A. Choughule

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
A. Choughule, Anuradha Bharat Choughule, Anuradha Choughule
Publication record
37 papers · 406 citations · H-index 10

PAPERS

Genomic Characterization of Papillary Thyroid Cancer Reveals Germline Mutations Associated With Congenital Hypothyroidism
20251 citationsauthor #7
Assessment of plasma derived microbiome profiles in lung cancer using targeted and whole exome sequencing
20250 citationsauthor #18
Comprehensive Genomic Profiling of 1,000 Indian Cancer Genomes Identify Opportunity of Precision Medicine: A Retrospective Cohort Study
20250 citationsauthor #48
Comprehensive Genomic Profiling of Anaplastic Thyroid Cancer Identifies Alterations in THRA, a Potential Modifier of Cellular Plasticity.
20250 citationsauthor #7
Effect of longitudinal ctDNA monitoring with resistance genomic signatures on prognostication in patients with EGFR-mutated advanced NSCLC.
20240 citationsauthor #7
Abstract 2408: Comprehensive genomic profiling of ctDNA reveals distinct genomic signatures and therapeutic implications for immunotherapy response in advanced head and neck cancer
20241 citationsauthor #7
Empowering precision medicine in rural India by establishment of a molecular genetics laboratory in Bihar: A prospective observational study
20240 citationsauthor #5
Artificial Intelligence Predicts Sensitivity of EGFR Novel Mutations to Tyrosine Kinase Inhibitors
20240 citationsauthor #13
Deep Diving Into the Fusion Across Cancer Types in the Indian Population From Formalin-Fixed Paraffin-Embedded RNA-Exome Data: A Road to Discovering Novel Rearrangements With Clinical Relevance
20240 citationsauthor #10
Optimization of Tissue Handling and Processing in the Era of Precision Medicine: A Practical Recommendation from a Multidisciplinary Panel of Indian Experts
20232 citationsauthor #7
Crizotinib induces Par-4 secretion from normal cells and GRP78 expression on the cancer cell surface for selective tumor growth inhibition.
20232 citationsauthor #9
Association of Cutibacterium acnes with human thyroid cancer
20238 citationsauthor #20
Understanding the Impact of Population and Cancer Type on Tumor Mutation Burden Scores: A Comprehensive Whole-Exome Study in Cancer Patients From India
20231 citationsauthor #9
Targeted next generation sequencing (NGS) enables identification of rare EGFR exon-20 insertion (p.H773_V774insPHPH) in lung adenocarcinoma patient
20233 citationsauthor #7
Identification of a rare EGFR exon 18 mutation in lung adenocarcinoma using targeted next-generation sequencing as a tool for precision medicine
20235 citationsauthor #7
Identification of EGFR mutations in type II papillary renal cell carcinoma
20231 citationsauthor #8
Characteristics and clinical outcomes of pulmonary sarcomatoid carcinoma: experience from Tata Memorial Centre
20221 citationsauthor #9
Impact of Molecular Tumor Board on the Clinical Management of Patients With Cancer
202219 citationsauthor #3
Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutation
20229 citationsauthor #7
Clinical Utility of Liquid Biopsy (Cell-free DNA) Based EGFR Mutation Detection Post treatment Initiation as a Disease Monitoring Tool in Patients With Advanced EGFR-mutant NSCLC.
202211 citationsauthor #2
Molecular characterization of lung squamous cell carcinoma tumors reveals therapeutically relevant alterations
202125 citationsauthor #10
Pulmonary sarcomatoid carcinoma: Retrospective analysis from a single center.
20210 citationsauthor #11
Excellent response to erlotinib in breast carcinoma with rare EGFR mutation—a case report
202010 citationsauthor #5
ROS1 rearrangement testing: Is immunohistochemistry changing the horizon?
20196 citationsauthor #1
Liquid biopsy in lung cancer-hope or hype?
201910 citationsauthor #1
Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer
201862 citationsauthor #2
P1.01-44 Outcome of Uncommon EGFR Mutation Positive Newly Diagnosed Advanced NSCLC Patients: A Single-Centre Retrospective Analysis
20180 citationsauthor #2
P2.09-10 qRT-PCR as an Efficient and Reliable Diagnostic Screening Approach for the Detection of EML4-ALK Fusion Gene in NSCLC Samples: A Pilot Study
20181 citationsauthor #1
ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer
201843 citationsauthor #15
Tyrosine Kinase Inhibitor versus Physician Choice Chemotherapy in Second-Line Epidermal Growth Factor Receptor Mutation Non-Small Cell Lung Cancer: Post hoc Analysis of Randomized Control Trial
20180 citationsauthor #5
P1.01-024 Plasma Circulating cfDNA as a Potential Biomarker in Clinical Management of NSCLC: Experience of Tata Memorial Hospital, India
20170 citationsauthor #1
Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma
201763 citationsauthor #4
Epidermal growth factor receptor exon 20 mutation in lung cancer: types, incidence, clinical features and impact on treatment
201738 citationsauthor #2
Drug-sensitive FGFR3 mutations in lung adenocarcinoma
201644 citationsauthor #23
CRE: a cost effective and rapid approach for PCR-mediated concatenation of KRAS and EGFR exons
20151 citationsauthor #6
Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer
20148 citationsauthor #1
Epidermal growth factor receptor mutation subtypes and geographical distribution among Indian non-small cell lung cancer patients.
201332 citationsauthor #1

TIMELINE

2013 32 citations

2014 8 citations

2015 1 citations

2016 44 citations

2017 101 citations

2018 106 citations

2019 16 citations

2020 10 citations

2021 25 citations

2022 40 citations

2023 22 citations

2024 1 citations

2025 1 citations

A. Choughule

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT